These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 24977684
1. Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Subramanian AK. Curr Opin Infect Dis; 2014 Aug; 27(4):316-21. PubMed ID: 24977684 [Abstract] [Full Text] [Related]
2. Mycobacterium tuberculosis in solid organ transplant donors and recipients. Malinis M, Koff A. Curr Opin Organ Transplant; 2021 Aug 01; 26(4):432-439. PubMed ID: 34074939 [Abstract] [Full Text] [Related]
3. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Sidhu A, Verma G, Humar A, Kumar D. Transplantation; 2014 Sep 27; 98(6):671-5. PubMed ID: 24825525 [Abstract] [Full Text] [Related]
4. Treating tuberculosis in solid organ transplant recipients. Sun HY. Curr Opin Infect Dis; 2014 Dec 27; 27(6):501-5. PubMed ID: 25211360 [Abstract] [Full Text] [Related]
5. Mycobacterial infections in solid organ transplant recipients. Meije Y, Piersimoni C, Torre-Cisneros J, Dilektasli AG, Aguado JM, ESCMID Study Group of Infection in Compromised Hosts. Clin Microbiol Infect; 2014 Sep 27; 20 Suppl 7():89-101. PubMed ID: 24707957 [Abstract] [Full Text] [Related]
6. Tuberculosis transmission across three states: The story of a solid organ donor born in an endemic country, 2018. Jones JM, Vikram HR, Lauzardo M, Hill A, Jones J, Haley C, Seaworth B, Oldham S, Brown M, Gutierrez F, Basavaraju SV. Transpl Infect Dis; 2020 Dec 27; 22(6):e13357. PubMed ID: 32510808 [Abstract] [Full Text] [Related]
7. Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: A comprehensive review. Abad CLR, Razonable RR. Transpl Infect Dis; 2018 Oct 27; 20(5):e12971. PubMed ID: 30055041 [Abstract] [Full Text] [Related]
8. Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018. Malinis M, La Hoz RM, Vece G, Annambhotla P, Aslam S, Basavaraju SV, Bucio J, Danziger-Isakov L, Florescu DF, Jones JM, Rana M, Wolfe CR, Michaels MG. Transpl Infect Dis; 2022 Apr 27; 24(2):e13800. PubMed ID: 35064737 [Abstract] [Full Text] [Related]
9. Incidence of tuberculosis in deceased-organ donors and transmission risk to recipients in Spain. Coll E, Torre-Cisneros J, Calvo R, Garrido G, Matesanz R. Transplantation; 2013 Jul 27; 96(2):205-10. PubMed ID: 23774810 [Abstract] [Full Text] [Related]
10. Prevention and treatment of tuberculosis in solid organ transplant recipients. Abad CL, Razonable RR. Expert Rev Anti Infect Ther; 2020 Jan 27; 18(1):63-73. PubMed ID: 31826668 [Abstract] [Full Text] [Related]
11. Management and outcome of latent tuberculosis in living renal transplant donors. Habhab WT, Alraddadi BM, Idris N, Alghamdi S, Zabani N, Fahmy A, Malik AA, Alwaassia M. Saudi J Kidney Dis Transpl; 2019 Jan 27; 30(1):151-152. PubMed ID: 30804276 [Abstract] [Full Text] [Related]
12. Transplantation-transmitted tuberculosis--Oklahoma and Texas, 2007. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2008 Apr 04; 57(13):333-6. PubMed ID: 18385639 [Abstract] [Full Text] [Related]
13. [The clinical application of quantiferon TB-2G: its usefulness and limitations]. Sato S, Nagai H. Kekkaku; 2011 Feb 04; 86(2):101-12. PubMed ID: 21404654 [Abstract] [Full Text] [Related]
14. Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan. Chiang CY, Chen CH, Feng JY, Chiang YJ, Huang WC, Lin YJ, Huang YW, Wu HH, Lee PH, Lee MC, Shu CC, Wang HH, Wang JY, Wu MY, Lee CY, Wu MS. J Formos Med Assoc; 2023 Oct 04; 122(10):976-985. PubMed ID: 37183074 [Abstract] [Full Text] [Related]
15. QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB. Ahmadinejad Z, Azmoudeh Ardalan F, Razzaqi M, Davoudi S, Jafarian A. Transpl Infect Dis; 2013 Feb 04; 15(1):90-5. PubMed ID: 23173720 [Abstract] [Full Text] [Related]
16. Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020. Katrak S, Han E, Readhead A, Fung M, Keh C, Flood J, Barry P. Am J Transplant; 2023 Mar 04; 23(3):401-407. PubMed ID: 36695700 [Abstract] [Full Text] [Related]
17. Performance of QuantiFERON TB gold test compared with the tuberculin skin test for detecting latent tuberculosis infection in lung and heart transplant candidates. Mardani M, Farshidpour M, Nekoonam M, Varahram F, Najafizadeh K, Mohammadi N, Sharifkashani B, Gachkar L, Farokhzad B, Droudinia A, Javanmard P, Tabarsi P. Exp Clin Transplant; 2014 Apr 04; 12(2):129-32. PubMed ID: 24702145 [Abstract] [Full Text] [Related]
18. Mycobacterium tuberculosis-associated immune reconstitution syndrome in solid-organ transplant recipients. Sun HY, Munoz P, Torre-Cisneros J, Aguado JM, Lattes R, Montejo M, Garcia-Reyne A, Bouza E, Valerio M, Lara R, John GT, Bruno D, Singh N. Transplantation; 2013 May 15; 95(9):1173-81. PubMed ID: 23435454 [Abstract] [Full Text] [Related]
19. Prevalence of active tuberculosis infection in transplant recipients: A systematic review and meta-analysis. Mamishi S, Pourakbari B, Moradzadeh M, van Leeuwen WB, Mahmoudi S. Microb Pathog; 2020 Feb 15; 139():103894. PubMed ID: 31805320 [Abstract] [Full Text] [Related]
20. [Prophylaxis against tuberculosis in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation]. Lafourcade M. Rev Chilena Infectol; 2012 Sep 15; 29 Suppl 1():S45-7. PubMed ID: 23282557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]